封面
市場調查報告書
商品編碼
1660977

過敏免疫療法市場報告,按治療類型(皮下免疫療法、舌下免疫療法)、過敏類型、配銷通路和地區分類,2025 年至 2033 年

Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ), Allergy Type, Distribution Channel, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球過敏免疫療法市場規模達到 34 億美元。推動市場發展的因素包括過敏症盛行率不斷上升、人們對免疫療法作為過敏症有效治療方法的認知不斷提高、免疫療法治療和技術的重大發展、政府對過敏研究的優惠政策和資金支持、以及定製藥物和個人化治療方法。

過敏免疫療法,也稱為減敏或低敏療法,是針對對各種食物、藥物、蜂毒、草花粉和屋塵蟎等過敏原的過敏反應的預防性醫療方法。它透過逐漸增加過敏原的劑量來改變免疫系統的反應。在治療開始之前,過敏症專家和患者會分析過敏症狀的誘發因素,這可能涉及皮膚和血液檢查以確認過敏原。過敏免疫療法有助於減少發炎、提供長期影響、增強免疫耐受性、改變疾病進程並改善患者的生活品質。

近年來,由於各種環境和生活方式因素影響了免疫系統的功能,世界各地過敏症的盛行率上升。隨著人們對過敏免疫療法認知的不斷提高、收入水平的提高和醫療保健支出的增加,對複雜和長期治療方案的需求正在增加,這反過來又刺激了市場的成長。由於世界各國政府和非政府組織採取了多項舉措,臨床研究和開發預算的不斷增加進一步支持了這項進程。此外,利用最新的藥物開發技術,製藥公司已經創造出更有效的免疫療法,可成功治療多種過敏。這一趨勢加上過敏診斷領域的進步,正在催化全球過敏免疫療法市場的成長。

本報告解答的關鍵問題

  • 2024 年全球過敏免疫療法市場規模? 2025-2033 年全球過敏免疫療法市場的預期成長率是多少?
  • 推動全球過敏免疫療法市場發展的關鍵因素有哪些?
  • COVID-19 對全球過敏免疫療法市場有何影響?
  • 根據治療類型,全球過敏免疫療法市場如何分佈?
  • 根據過敏類型,全球過敏免疫療法市場如何分佈?
  • 根據配銷通路,全球過敏免疫療法市場分佈如何?
  • 全球過敏免疫療法市場的主要地區有哪些?
  • 全球過敏免疫療法市場的主要參與者/公司有哪些?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球過敏免疫療法市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場區隔:按治療類型
  • 市場區隔:依過敏類型
  • 市場區隔:按配銷通路
  • 市場分佈:按地區
  • 市場預測

第6章:市場區隔:依治療類型

  • 皮下免疫治療 (SCIT)
    • 市場趨勢
    • 市場預測
  • 舌下免疫治療 (SLIT)
    • 市場趨勢
    • 市場預測

第 7 章:市場區隔:依過敏類型

  • 過敏性鼻炎
    • 市場趨勢
    • 市場預測
  • 氣喘
    • 市場趨勢
    • 市場預測
  • 食物過敏
    • 市場趨勢
    • 市場預測
  • 毒液過敏
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章:市場區隔:按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥局
    • 市場趨勢
    • 市場預測
  • 網路藥局
    • 市場趨勢
    • 市場預測

第9章:市場細分:依地區

  • 歐洲
    • 市場趨勢
    • 市場預測
  • 北美洲
    • 市場趨勢
    • 市場預測
  • 亞太地區
    • 市場趨勢
    • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 市場預測
  • 拉丁美洲
    • 市場趨勢
    • 市場預測

第 10 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章:價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第 14 章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Stallergenes Greer
    • HAL Allergy Holding BV
    • DBV Technologies
    • Merck KGaA
    • Aimmune Therapeutics
    • Circassia Pharmaceuticals
    • Anergis SA
    • Biomay AG
Product Code: SR112025A1401

The global allergy immunotherapies market size reached USD 3.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.5 Billion by 2033, exhibiting a growth rate (CAGR) of 8.29% during 2025-2033. The market is propelled by the rising prevalence of allergic conditions, increasing awareness about immunotherapy as an effective treatment for allergies, significant developments in immunotherapy treatments and technologies, favorable government policies and funding for allergy research, and customized medicine and tailored treatment approaches.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

Breakup by Treatment Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Key Questions Answered in This Report

  • 1.What was the size of the global allergy immunotherapies market in 2024?
  • 2.What is the expected growth rate of the global allergy immunotherapies market during 2025-2033?
  • 3.What are the key factors driving the global allergy immunotherapies market?
  • 4.What has been the impact of COVID-19 on the global allergy immunotherapies market?
  • 5.What is the breakup of the global allergy immunotherapies market based on the treatment type?
  • 6.What is the breakup of the global allergy immunotherapies market based on the allergy type?
  • 7.What is the breakup of the global allergy immunotherapies market based on the distribution channel?
  • 8.What are the key regions in the global allergy immunotherapies market?
  • 9.Who are the key players/companies in the global allergy immunotherapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Treatment Type
  • 5.5 Market Breakup by Allergy Type
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Subcutaneous Immunotherapy (SCIT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sublingual Immunotherapy (SLIT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Allergy Type

  • 7.1 Allergic Rhinitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Food Allergy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Venom Allergy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Europe
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 North America
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ALK-Abello A/S
    • 14.3.2 Allergy Therapeutics
    • 14.3.3 Stallergenes Greer
    • 14.3.4 HAL Allergy Holding B.V.
    • 14.3.5 DBV Technologies
    • 14.3.6 Merck KGaA
    • 14.3.7 Aimmune Therapeutics
    • 14.3.8 Circassia Pharmaceuticals
    • 14.3.9 Anergis SA
    • 14.3.10 Biomay AG

List of Figures

  • Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
  • Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2024
  • Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2024
  • Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
  • Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
  • Figure 10: Global: Allergy Immunotherapies Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million USD), 2019 & 2024
  • Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million USD), 2025-2033
  • Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million USD), 2019 & 2024
  • Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million USD), 2025-2033
  • Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million USD), 2019 & 2024
  • Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million USD), 2025-2033
  • Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million USD), 2025-2033
  • Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Allergy Immunotherapies Market Structure
  • Table 7: Global: Allergy Immunotherapies Market: Key Players